Get Our e-AlertsSubmit Manuscript
Research / 2022 / Article

Review Article | Open Access

Volume 2022 |Article ID 9758491 |

Yanni Wang, Gehua Ma, Guangzhi Gao, Ji Tao, Wenzhao Cao, Haohao Sun, Fengsen Ma, Yilong Zhang, Yen Wei, Mei Tian, "Bioimaging of Dissolvable Microneedle Arrays: Challenges and Opportunities", Research, vol. 2022, Article ID 9758491, 23 pages, 2022.

Bioimaging of Dissolvable Microneedle Arrays: Challenges and Opportunities

Received19 Feb 2022
Accepted10 Jun 2022
Published01 Aug 2022


The emergence of microneedle arrays (MNAs) as a novel, simple, and minimally invasive administration approach largely addresses the challenges of traditional drug delivery. In particular, the dissolvable MNAs act as a promising, multifarious, and well-controlled platform for micro-nanotransport in medical research and cosmetic formulation applications. The effective delivery mostly depends on the behavior of the MNAs penetrated into the body, and accurate assessment is urgently needed. Advanced imaging technologies offer high sensitivity and resolution visualization of cross-scale, multidimensional, and multiparameter information, which can be used as an important aid for the evaluation and development of new MNAs. The combination of MNA technology and imaging can generate considerable new knowledge in a cost-effective manner with regards to the pharmacokinetics and bioavailability of active substances for the treatment of various diseases. In addition, noninvasive imaging techniques allow rapid, receptive assessment of transdermal penetration and drug deposition in various tissues, which could greatly facilitate the translation of experimental MNAs into clinical application. Relying on the recent promising development of bioimaging, this review is aimed at summarizing the current status, challenges, and future perspective on in vivo assessment of MNA drug delivery by various imaging technologies.

1. Introduction

Microneedle arrays (MNAs) are emerging as a promising physical enhancement technique for transdermal delivery systems, which is capable for breaching the skin barrier to controlled bioactive ingredients release and delivery. Compared with the conventional injections, MNA-based drug delivery has the advantages such as reduction of pain, minimal invasiveness, high efficiency, better patient compliance, and intelligent response [1, 2]. Typically, a patch of MNAs consists of tens to hundreds of needles 300-1000 μm long with 1-20 μm tips attached to a backing layer. The size of microneedles lies between the macroscopic (0.1 mm-1 km) and mesoscopic (1-100 nm) scales of matter, similar to that of microelectromechanical systems (MEMS), which is between submicron (0.1 μm-1 μm) to submillimeter (0.1 mm-1 mm) (Figure 1). Thus, the evaluation of micron-sized MNA drug delivery system requires high spatial resolution of transdermal penetration depth and high sensitivity of imaging agent, which differs significantly from those used for conventional drug delivery systems in animals and humans [3]. The observation of molecular or cellular microstructures from nanometer to a few microns in size usually requires the assistance of electron microscope (EM), or super-resolution microscopy (SRM) which is beyond the diffraction barrier and enhances the spatial resolution [4]. In contrast, macroscopic optical imaging focuses on the whole body. Other imaging modalities including digital radiography (DR), computed tomography (CT), magnetic resonance imaging (MRI), positron emission computed tomography (PET), and PET-CT have been extensively applied in clinical practice with favorable tissue penetration depth and limited spatial resolution at the millimeter level [5]. The depth of penetration, signal-to-background contrast, and spatial resolution are essential for a promising imaging technique. Evaluating the tissue penetration performance of micro-nanoscale medical products like MNAs particularly requires the ability to balance imaging depth and resolution, which is a challenge for imaging technology. These demanding requirements are equally important for studying the in vivo kinetics of other MEMS-scale products formed by bioactive components in tiny spaces, such as biosensors, biochips, smart wearable devices, and intelligent drug delivery systems [610]. Advanced imaging techniques are essential to identify and characterize these multiscale and multilevel macroscopic or microscopic changes [11].

Dissolvable MNAs, also known as polymeric MNAs, including those of soluble and biodegradable, are considered a more acceptable option than injections in delivering drugs, vaccines, and cosmetics to the skin, paving a new pathway for improving patient compliance and achieving on-demand drug release [12, 13] (Figure 2). Typically, microneedle can be a homogeneous needle body or loaded with various nanoparticles that, when pierced into the body, involves a series of complex processes such as absorption, swelling, dissolution, degradation, and diffusion to achieve instant, sustained, or targeted release of the drug [13, 14] (Figures 2 and Figure 3). Dissolvable MNAs are mainly composed of polymers including chitosan, hyaluronic acid (HA), cellulose derivatives, and synthetic polymeric materials such as polyvinylpyrrolidone (PVP), polylactic acid-hydroxyacetic acid (PLGA) [12, 14, 15], and it is noteworthy that the mechanical strength is not as strong as that of metal or monocrystalline silicon. The penetration depth of dissolvable MNAs into the skin determines the drug delivery efficiency; thus, further research is needed to make use of optimized imaging methods to better identify the insertion performance of MNAs. The assessment of skin penetration capability of dissolvable MNAs has received much attention in recent years [1619]. Imaging techniques that can provide millimeter-level depth and micron-level resolution, as well as noninvasive and real-time observation, will play a significant role in the objective evaluation of microneedle penetration effects, pharmacokinetic studies, and the establishment of quality control system for MNAs.

The previous approaches used to evaluate the penetration effect of MNAs were mainly conventional imaging techniques, such as optical microscopy or fluorescence microscopy (for observing the results of parafilm puncture or tissue sections) and ultrasound imaging (USI). Optical coherence tomography (OCT) [20, 21], confocal laser scanning microscopy (CLSM), CT, photoacoustic microscopy (PAM), and two-photon microscopy (TPM) are advanced imaging methods that can provide more detailed imaging results or rely on more sophisticated techniques. The operating frequencies of USI and MRI are MHz-level (millimeters or submillimeter), those of OCT/CLSM/TPM are mainly in the range of hundred nanometers or micrometers, and CT operates at frequencies commonly referred to as ultrashortwave X-rays of less than 10 nm. All the imaging modalities mentioned above differ in their effective detection depth, spatial resolution, accuracy, and real-time.

Understanding the application of imaging techniques and tracking those applicable and advanced real-time imaging techniques, such as OCT, can not only help us improve the objective analysis of dissolvable MNA penetration depth and drug distribution to guide the design, optimization, and refinement of MNA products to better meet clinical needs, but also provide new directions for improvement of general imaging tools from the perspective of this unique application and expand their further practical applications in the fields of medicine and life sciences.

2. Conventional Imaging Technologies

The adoption of optical imaging and ultrasonography etc. are all conventional imaging methods for evaluating MNA insertion depth (Figure 4). Among optical methods, the parafilm puncture is widely used as an in vitro approach to simulate skin puncture, and tissue sectioning is the most classic imaging method.

2.1. Optical Imaging

The observation was done after the MNAs penetrate into the parafilm and the skin is mostly carried out with an ordinary optical microscope, and the different magnifications can be obtained (Figure 3 (a and a1)). The parafilm is a flexible thermoplastic sheet made of olefin materials, which is usually used as an artificial skin model to evaluate the penetration depth of MNA puncture in vitro [30]. Generally, eight layers of parafilm were superimposed and subsequently fixed on a polystyrene plastic foam plate or other materials. The MNAs were inserted into the aforementioned layer under a certain external force. Finally, the puncture of each layer was observed with an optical microscope, and the number of layers punctured was counted to estimate the penetration depth (Figure 4). The number of holes in the parafilm was easily visible to the naked eye. For a more convenient observation, the parafilm layer can be placed between two polarizing filters [31], or the Zeta profiler [32] can be applied to identify the number of holes. At the same time, the size of the pores in the parafilm can also be utilized to characterize the uniformity of the needle’s diameter and length of the MNAs [33]. Simple and intuitive, easy feasible to operate, and inexpensive are of utmost advantages for such a method. However, when superimposed on a parafilm with a thickness of more than 120 μm, the underlying layer can sometimes only be concave rather than perforated by the MNAs, which inevitably leads to counting errors. Hence, the search for novel and more suitable alternatives is urgently needed [19].

Histological sectioning is a common approach in pathological research, and it is also selected for evaluating the penetration depth of MNAs [34]. The skin punctured by the MNAs is usually cut into 6-12 μm slices, stained with hematoxylin and eosin (H&E) or fluorescent dyes, and then observed under light or fluorescence microscopy as well as a panoramic scanner [22, 35] (Figures 3 and 5(b)). Through the corresponding software processing and analysis, the size of the microchannel and finally the penetration depth can be measured. Park et al. [36] used carboxymethyl cellulose MNAs to penetrate pig skin and the penetration depth was about 200 μm, but the slices obtained here were deformed. Compared with the preceding paraffin puncture method, the histological section provides a more accurate and intuitive evaluation, but the skin sample may be deformed and displaced during the preparation, leading to the results that are at variance with reality. Furthermore, staining is also a significant factor for imaging. More research involving imaging optimization is focused on virtual imaging to obtain higher image quality. Researchers have tried to use conditional generative adversarial networks (cGANs) to accept the autofluorescent of nonstained biological tissue with whole slide images and computationally stain them by learning hierarchical nonlinear mappings between image pairs before and after H&E staining [37]. A recent study presented the ability to create a label-free virtual H&E image, but it requires physical contact between the ultrasonic transducer and the sample to measure the generated sound waves [38]. In general, the slice imaging process based on algorithm analysis faces the time and economic pressures.

2.2. Ultrasound Imaging

Ultrasound imaging (USI), based on the detection of objects and measurement of distances by ultrasound, is usually applied for monitoring industrial product quality [39] and clinical disease diagnosis [40] (Figure 4). Indeed, USI was often used as an external auxiliary means to overcome the obstacles of the stratum corneum to promote the permeability of drug transdermal delivery [41]. Nguyen and Banga [33] used the DermaScan ultrasonic diagnostic instrument to perform USI of the isolated skin punctured by the PLGA MNAs for the first time and to evaluate the microporous channels in the skin. However, due to the low-resolution and unclear imaging, the apparatus can only provide a qualitative rather than a quantitative measurement of microchannel size, and it is difficult to clearly distinguish the various layers of the skin.

2.3. Magnetic Resonance Imaging

A recent study reported a programmable polymeric MNA made of PVP, polydopamine/manganese dioxide (termed PDA@MnO2), and methotrexate for the treatment of rheumatoid arthritis (RA) [42]. PDA@MnO2 can be used as an MRI contrast agent in the synovial microenvironment of RA. Other researchers performed the depth statistics after the MRI of cross-section of PLGA MNAs inserted into the skin of pigs and obtained the results of penetration depth equivalent to 75% of the total needle length [43]. Also, the dyes such as trypan blue were employed to stain the skin and observed under an ordinary microscope, presenting the overall puncture effect of an MNA patch [33, 44]. However, it is difficult to accurately measure the ratio of the skin portion punctured inside to that remaining outside.

It can be estimated the length penetrated of the microneedles after piercing the skin by subtracting the residual needle body from the total length (Figure 4) [45], and quantification is typically performed using optical microscopy coupled with comprehensive imaging software [46]. Although this method is easy to implement, it is almost impossible to know the exact penetration depth and amount due to unpredictable factors such as the occurrence of mechanical damage during insertion or extraction and the partial dissolution of microneedles on the skin surface, all of which add to the complexity. Thus, the measurement of residual length based on microscopic imaging techniques to study the penetration of MNAs and their length over time is still quite good.

3. Advanced Imaging Technologies

The above imaging techniques used for evaluation MNA penetration efficiency are either cumbersome and time-consuming to produce, such as tissue sections, or have low accuracy as in the case of parafilm puncture. USI, although capable of providing real-time observations, does not meet the evaluation requirements due to the low imaging resolution. There is a need to rely on more advanced and effective imaging techniques to address some or all of these challenges. OCT, CLSM, TPM, PAM, and CT are some excellent techniques and hold the crucial advantages of providing real-time, noninvasive, in situ, or in vivo images of the MNA penetration, dissolving, or swelling in the skin.

3.1. Two-Photon Fluorescence Imaging

The penetration depth of two-photon microscopy (TPM) imaging varies widely between tissue types, with hundreds of micrometers deep cell imaging in various organs of living animals [47], and for highly transparent tissues (e.g., the cornea), imaging depths of more than 1 mm can be achieved [48]. Current studies of TPM for MNA penetration depth usually rely on the imaging generated by transdermal action of the drug loaded by MNAs [49]. Chiu et al. [50] used TPM to image and observed the microholes punctured by the MNAs. The observation provided further evidence that nanoparticles can function as reservoirs for lipophilic drugs and thereby enable the sustained and controlled delivery of multiple compounds. Notably, TPM imaging should be performed 20-30 minutes after applying MNAs owing to excessive sample preparation time [51]. TPM microscopy can be well imaged with the second harmonic of the skin tissue itself, which makes the collagen fibers in the dermis fluoresce blue, while the stratum corneum has strong green autofluorescence and the epidermis has no fluorescent signal, so that the various tissue layers of the skin show different color signals, which has obvious advantages compared to fluorescent dye-stained imaging specimens.

3.2. Photoacoustic Imaging

Photoacoustic imaging (PAI) techniques such as photoacoustic tomography (PAT), photoacoustic computed tomography (PACT), and photoacoustic microscopy (PAM) have the unique ability to penetrate deeper and sustain higher spatial resolution. Compared to USI, PAT has rich intrinsic and extrinsic optical contrasts and is free of speckle artifacts that occur during OCT translucent tissue imaging [52]. The penetration depth is less than 100 μm in acoustic resolution photoacoustic microscopy (AR-PAM), while a lateral resolution up to 0.5 μm and a maximum of 1.2 mm inside the biological tissue [53] can be achieved in optical resolution photoacoustic microscopy (OR-PAM).

In vivo structural, functional, molecular, and cellular imaging has made extensive use of PAI [5456] (Figure 6). PAI has been successfully applied to characterize the transdermal delivery of nanoparticles using MNAs [57]. Additionally, structured illumination microscopy (SIM) has enabled wide-field fluorescence imaging to break through the resolution limitations of conventional lenses and has become a key technique for the observation of microscopic objects in cell biology. Ferrara et al. [58] used the optical principle of SIM to facilitate the resolution of USI by manipulating the transmitted acoustic field and mixing high spatial frequency codes into the image. SIM also has been shown to be able to provide accurate lifetime measurements when used in conjunction with fluorescence lifetime imaging microscopy (FLIM). The intensity of a fluorophore depends on its concentration. However, the lifetime of a fluorophore is mostly independent of its concentration. The fluorescence lifetime is also independent of the irradiated laser intensity and photobleaching, which makes fluorescence lifetime imaging advantageous in thick tissue imaging [59].

3.3. Confocal Laser Scanning Microscopy

Confocal laser scanning microscopy (CLSM) achieves optical sectioning of thick specimens by eliminating the defocus signal and can realize imaging scanning for both ex vivo and in vivo skin. Moreover, CLSM can provide images of the epidermal and upper dermis cell layers and distinguish the blood flow in the capillaries in each dermal papilla and identify individual circulating blood cells with high resolution. Imaging at a depth of about 100-350 μm below the stratum corneum allows the detection of collagen fibers, sebaceous glands, sweat ducts in the dermal papilla, and superficial mesh network [60]. The abovementioned imaging of the skin microstructure is useful for studying cellular or microvascular damage during MNA penetration, and the clearer imaging of skin microstructure is also the basis for MNA safety assessment. CLSM can also be combined with the Z-stack scanning to measure the actual depth of the micropores created by the MNA penetration in the skin [61]. The strongest barrier of CLSM compared to OCT is that the penetration depth is only a few hundred microns and is limited to the superficial dermal papillary region [62], because the multiple scattering at deeper depths causes the signal-to-noise ratio to decrease with increasing imaging depth. Due to the limitation of imaging depth, CLSM is not suitable for evaluating the penetration depth of long-sized microneedles.

The common types of depth detection used to evaluate MNA insertion depth with CLSM are shown in Table 1. CLSM often locates the MNA penetration depth by means of fluorescent dyes labeling (Figure 5(c)). Through tomographic imaging of the fluorescent substance of different depths, the visibility of the fluorescent materials is used to evaluate the penetration depth of the MNAs [63], but the intensity of the fluorescent signal is limited within a certain time range [64]. The penetration and diffusion of fluorescent dyes will also make errors in the evaluation of MNA penetration depth, and the final result is often overestimated than that of tissue section [65] or the actual insertion depth. More accurate results are often obtained depending on the inherent fluorescent properties of the skin tissue or loaded active ingredient itself compared to exogenous fluorescent labeling.

CategoryMethodsInsertion depth observedDimensions of MNAsFabricating materials of MNAsTherapeutic use

Fluorescent labeledAdded FITC fluorescent substance to observe the fluorescence intensity at different depths after MNA penetration [65]About 650 μmShape: cone
Height: 900 μm
GelCSDiabetes treatment
Used rhodamine B as a model drug and its fluorescence characteristics to image different depths of micropores formed by MNAs [63]About 500 μmShape: pyramid
Height: 650 μm
Alg-APBA/HADiabetes treatment
Used Rhodamine B and Coumarin C6 as model drugs and their fluorescence properties to image MNA penetration depth [66]About 300 μmShape: pyramid
Height: 600 μm
HA; PVPK17Psoriasis and arthritis treatment
Added methylene blue to observe the fluorescence intensity at different depths after MNA penetration [67]About 125 μmShape: pyramid
Height: 400 μm
Drug labeledUsed the fluorescence characteristics of doxorubicin to study the depth of the micropores after MNA insertion [61]About 121.5 μmShape: pyramid
PVACancer treatment
Slice reconstructionScanned and reconstructed of skin slices punctured by MNAs [68]/Shape: pyramid
PLGA; PVASustained drug release
Combination of fluorescent labeling and reconstructionScanned stereo imaging of the in vitro skin of the penetration distribution of different amounts of drugs labeled with fluorescent dyes [46]About 155-209 μmShape: pyramid
Height: 300 μm
HAIntradermal protein delivery
Reduced fluorescence diffusionAfter MNA pretreatment, calcein was processed, and the different depths of the micropores of the isolated skin were scanned and imaged [33]About 115.5 μmShape: pyramid
PLGAImmunological diseases

/ : not available. GelCS: gelatin/calcium sulfate hemihydrate composites. Alg-APBA: 3-aminophenylboronic acid-modified alginate.
3.4. Optical Coherence Tomography Imaging

As a nondestructive “optical biopsy” form of imaging technology, OCT allows real-time and in situ imaging of tissue structures in vivo without the need to pretreat or damage the tissue [69], which has great potential for skin imaging applications. The stratum corneum, epidermis, the upper dermis of the skin, skin appendages, and blood vessels show different optical scattering coefficients; thus, the skin can represent a clear hierarchical structure in OCT imaging [70]. This structural information may provide the basis for rapid location and inspection for skin lesions (such as inflammation, edema, infiltration, and necrosis). Conventional OCT used for ophthalmic diagnosis displays strong multilayer tissue scattering and optical inhomogeneities in this challenging human skin imaging process [71]. Therefore, to obtain optimal imaging results, constant adjustment of OCT parameters is essential to maintain the imaging depth and resolution of the skin sample satisfy the requirements.

Many studies adopted OCT in the research of MNA insertion process, which greatly exerted the strengths of OCT in real-time detection (Figures 7(a)–7(f) and 5(a)). Table 2 lists some of these studies.

Bio-tissueResolution of the instrumentDetection limit or measured depth/rangeDimensions of MNAsFabricating materials of MNAsTherapeutic use

Ocular tissuesHorizontal resolution: 7.5 μm
Vertical resolution: 10 μm
Imaged insertion depth is about 600 μmShape: cone
Height: 800 μm
PVP [72]Model drug delivery (a fluorescent agent)
Skin models; isolated pig skin; abdominal skin of mice in vivoHorizontal resolution: 15 μm
Vertical resolution: 8 μm
Detection depth up to 3.4 mmShape: pyramid
Height: 2 mm, 800 μm, and 500 μm
Silk fibroin [74]/
Newborn pig skinHorizontal resolution: 7.5 μm
Vertical resolution: 10 μm
Scan width up to 2 mmShape: seven different shapes
Height: 280-900 μm
PMVE/MA [75]Antiasthma
Porcine small intestine tissueScan resolution up to 1.3 μm/Shape: pyramid
Height: 600-1200 μm
PVP [76]Diabetes treatment
Newborn pig skin/Imaged insertion depth was about 250-300 μmShape: cone
Height: 600 μm
PVP; PVA [77]Vitamin D3 delivery
Mouse back skinHorizontal resolution: 10 μm
Vertical resolution: ≥5 μm
Imaged insertion depth was about 700 μmShape: pyramid
Height: 800 μm
HA; PVP K90 [78]Melanoma therapy
Porcine scleral tissueHorizontal resolution: 7.5 μm
Vertical resolution: 10 μm
Imaged insertion depth was about Shape: cone
Height: 750 μm
PVP; PVA [29]Model drug delivery (ovalbumin)
Newborn pig ear skinHorizontal resolution: <7.5 μm
Vertical resolution: <5 μm
Detection depth up to 1 mmShape: pyramid
Height: 650 μm
HA; PVP; Maltose [79]Atrophic scars or photo-aged skin treatment
Full-thickness rat skin/Imaged insertion depth was about 300 μmShape: pyramid
Height: 600 μm
HA; PVP [66]Psoriasis and arthritis treatment
Porcine skinHorizontal resolution: 10 μm
Vertical resolution: 7 μm
The physical scanning range was Shape: pyramid
Height: about 600 μm
Gelatin; CMC [80]Diabetes treatment
Neonatal porcine skinHorizontal resolution: 7.5 μm
Vertical resolution: 10 μm
/Shape: pyramid
Height: 630 μm
PMVE/MA; PEG 10,000 [81]/
Mouse skinHorizontal resolution: 7 μm
Vertical resolution: 6 μm
The physical scanning range was Shape: pyramid
Height: 630 μm
Arrays: 351
PVP; PVA [82]Model drug delivery (rhodamine)

/ : not available. PMVE/MA: copolymer of methylvinylether and maleic anhydride.
3.5. CT Scanning

Computer-assisted tomography (CT) is an imaging technology for clinical diagnosis, which uses collimated X-rays and extremely sensitive detectors for cross-sectional scanning with strong tissue penetration [83]. Micron-scale computed tomography (micro-CT) can provide higher resolution and obtain information about the microstructure and composition of tissues [84]. Loizidou et al. [73] combined micro-CT scan imaging and finite element analysis to study how the geometric composition of the MNAs affects the penetration characteristics. micro-CT uses a series of X-ray scans taken at different angles to generate voxel and visualize MNA insertion in three-dimension (3D) (Figures 7(g) and 7(h)). It is worth noting that it took three hours to use CT scan imaging, during which the rebound characteristics of the skin may affect the original actual penetration effect. Abramson et al. [76] used micro-CT to evaluate the penetration ability of enteric-coated MNAs and developed a luminal unfolding microneedle injector to consistently deliver insulin-loaded dissolvable MNAs into intestinal tissue, which builds a platform to deliver the macromolecule drugs.

Polymer hollow microneedles are preferable choice for enabling to create a small, wearable and minimally invasive closed-loop system. micro-CT is used to study the lumen in the microneedles in order to detect the presence of any blockage due to either debris or tapering owing to the fabrication method [9]. micro-CT scanning technology can help visualize whether all the needles in the array can pierce and penetrate the skin or observe if there are areas in the patch that cannot penetrate the skin due to mechanical failure. However, this approach is subject to certain limitations of radiation and others. Some of these include the difficulty in distinguishing the exact penetration layer of the skin, which hinders the visualization of MNA insertion and limits the quantitative assessment of penetration depth.

4. Characterization of MNAs

The physical characteristics of the MNAs affect the insertion effect as well as its in vivo action, which first requires a basic evaluation of certain parameters such as its homogeneity, length, sharpness, stiffness, and perpendicularity [85]. Imaging devices such as stereomicroscope [86], bright-field microscope [87], optical microscope, scanning electron microscope (SEM) (Figures 8(c), 8(g), and 8(h)), and fluorescence stereomicroscope are available for observation.

The distribution of the drug loaded by MNAs includes that of the needle tip, the needle body, and the entire MNA patch. Needle tip loading can ensure precise dosage and complete drug delivery (Figure 3). MNAs are usually labeled with fluorescent dyes such as FITC [29, 88] or rhodamine B [89] and observed by imaging under a fluorescent microscope (Figure 8(d)) or fluorescent Raman spectroscopy [90]. CLSM can effectively evaluate the tomography of microneedle bodies at different angles and characterize the distribution of drugs in the matrix of MNAs by detecting fluorescence signals [91] (Figure 8(e)). High-resolution transmission electron microscopy (HR-TEM) can be used to characterize the nanoparticles loaded in the MNA matrix [65].

5. Challenges, Opportunities, and Strategies

The evaluation of MNA skin insertion involves a complex interrelationship and requires finding a match between the microneedle, skin, and imaging techniques. Therefore, it is crucial to select the appropriate imaging modality based on skin characteristics or the composition of MNAs, to improve imaging results by using contrast agents or optical clearing agents (OCAs). Currently, researchers are still in the process of exploring an imaging technique that can allow detection of clear and accurate 3D dynamic imaging in vivo.

5.1. Challenges of MNA Imaging In Vivo

The in vivo dissolving and diffusion state is usually observed with the help of bright-field and fluorescence microscope [92] (Figure 9(a) (b1 and b2)), OCT, CLSM (Figure 9(c)), or in vivo optical imaging system (IVIS) in small animals. Also, with the help of near-infrared (NIR), photothermal conversion factors loaded in the drug can be used to determine the location of the drug based on temperature imaging [93].

Labeling the location of drugs, DNA, or proteins with fluorescence or exploiting their inherent fluorescent properties, is common in in vivo imaging techniques, such as in vivo bioluminescence imaging (BLI) and in vivo fluorescence imaging [94]. BLI can be used for directional analysis and simple quantitative calculations but cannot provide information about the depth of the luminescent source within the organism. IVIS imaging system, as a representative of in vivo fluorescence imaging technique, provides accurate localization of tomographic fluorescence imaging and drug distribution [95]. It is worth noting that in the case of mixing fluorescent agent and drug, the observed results only represent the location of the fluorescent agent but not the actual distribution of the drug.

The study of the overall distribution of MNAs after puncture into the body is relatively satisfactory, but its precise kinetic study which involves the inversion calculation is still difficult [95]. 3D structural images can be reconstructed via the difference in scattering coefficient between the dissolvable MNAs’ own material and biological tissue, or with the help of fluorescent imaging agents (Figure 5). However, there is still a great gap to achieve accurate quantification and 3D reconstruction imaging technology due to the following challenges: (1)The MNA itself has a limited capacity, with a standard conical needle length of 600 μm and bottom width of 200 μm for an array patch of needles, whose total volume of needle body is only 0.6 μL, and the imaging agents, drugs, and matrix materials carried are very limited(2)The skin is a complex elastomer that produces constraints and adverse effects during MNA insertion, making the penetration behavior of the MNAs in the arrays nonhomogeneous, i.e., the depth and angle of penetration may not be identical(3)Dissolvable MNAs will gradually dissolve, swell, or degrade after being pierced into the body. The differences between the dissolved, swelled, or degraded states and the solid state, possibly reflected in the differences in the absorption, reflection, refraction, and scattering of light waves(4)It is difficult to maintain the microstructure produced by MNA penetration due to the elasticity of skin tissue and the physical deformation of microneedles, especially when those invasive and destructive observation methods are used(5)In volumetric imaging, there are still certain technical bottlenecks in the resolution and accuracy of the imaging technology

The above issues will greatly increase the complexity of the considerations needed to improve the depth and resolution of the imaging and the 3D reconstruction methods, which may differ from the applications in medical and cell science research.

In addition, the penetration behavior of MNAs is more complex than that of single microneedle. The differences between the artificial simulated skin, animal skin, and human skin will lead to deviations between the predicted value, the actual situation, and the measured results [19]. These are also important issues when determining the penetration depth, drug loading, and distribution of MNAs using imaging techniques. In this regard, noninvasive high-resolution, high-penetration 3D dynamic imaging techniques will provide strong support for the development of MNA technologies and products. Considering the 3R principle (reduction, replacement, and refinement) to be followed in animal experiments, noninvasive imaging technology is of great significance not only for reducing the use of experimental animals, more in line with animal ethics, but also for the precision of detection results.

So far, the research penetration volume of MNAs is still in its initial stage. For example, in skin cosmesis, some studies have evaluated the effect of soluble MNAs loaded with adenosine in reducing wrinkles and quantitatively analyzed the reduction of wrinkles in two groups using a 3D dermatometer [96]. The depth and volume of wrinkles around the eye were measured by the PRIMOS compact based on the digital strip projection technique [24]. These detection methods are of reference significance for the MNA insertion volume, which shows that the demand for obtaining and analyzing the 3D data of skin has markedly increased in recent years.

Similarly, to better evaluate the MNA penetration volume, high-performance and robust algorithms including deep learning methods for MNA image segmentation and extraction are urgently needed. In order to overcome the limitation of multiple low-resolution images decoded from the optical field camera on the accurate 3D surface reconstruction required for tactile palpation, the depth map of generative adversarial networks (GAN) accurately estimates the skin surface depth map with high resolution. This aspect has attracted many research interests. More recently, Hassan et al. [97] presented a residual learning-based framework, dubbed RASP-Net, which adopts computer vision techniques such as atrous spatial pyramid pooling to achieve high-quality segmentation, demonstrating a promising future of computer vision-based MNA penetration volume evaluation.

5.2. Opportunities for Imaging Quality Improvement

Every imaging technology is based on the appropriate use of certain optical and other principles. However, the pathway to hardware and principal breakthroughs is not always open and endless. The ability to obtain high-definition images of biological tissue in micro- and nanospaces can also be achieved with the rational use of various imaging enhancers, such as imaging contrast or optical clearing agents, fluorophores, and multifunctional nanocarriers.

5.2.1. Principles of Applicable Imaging Technologies

When considering the principles that can guide the choose of appropriate imaging techniques applicable for evaluation of MNA penetration, the differences in the optical principles underlying these imaging techniques need to be clarified. From the perspective of a pharmacologist, photodynamics (PD) and photokinetics (PK) are both important in the optical imaging. The former refers to the action of light on the recipient object (biological tissue or other subjects), such as the effects of photoacoustic, photothermal, photoelectric, and photochemical reactions; the latter refers to the action of biological tissues on light, including reflection, refraction, absorption, diffusion, and scattering (Figure 10(a)).

Biological tissue is a multiphase inhomogeneous media with high scattering of light waves, through which only ballistic, serpentine, and diffuse photons can pass, with ballistic light being very weak and diffuse light being the strongest. The diffuse light is severely scattered in the medium and basically loses the coherence of the incident light, but contains the structural features of the medium, whereby the technique for laminar imaging is called diffuse optical tomography (DOT) with an imaging depth of 1-10 cm and a resolution of 500-1000 μm [53]. In the near-infrared (800-1700 nm) window, where the 650-1100 nm band is also known as the “tissue optical window,” biological tissues have minimal absorption, scattering, and autofluorescence, allowing higher penetration depths for noninvasive or minimally invasive deep tissue imaging [98] (Figure 10(b)). NIR activatable responsive MNAs have been widely used to achieve triggered release of bioactive substances for wound healing, cancer or diabetes treatment, etc. [22, 27, 93, 99].

Conventional fluorescence microscopes (including confocal) cannot achieve high-resolution depth imaging due to strong biological tissue scattering. Therefore, the biggest challenge in optical imaging is to overcome the scattering effect of tissues. OCT operates with ballistic photons, which are scattered only once. Therefore, OCT exhibits a short penetration depth in highly scattering tissue [101]. Confocal microscopic imaging improves the resolution of optical imaging by effectively suppressing the interference of diffracted light and scattered light. Compared with conventional optical microscopy, the light source is replaced by the laser, the scanning unit, and the pinhole on the back focal plane, thereby improving the limited focal depth [102].

TPM possesses the features of both CLSM and two-photon excitation techniques to achieve 3D laminarization through nonlinear optical excitation, allowing nondestructive high-resolution fluorescent molecular imaging and label-free 3D imaging in vivo [103]. This powerful bioanalytical method has the advantages of high photostability, low photodamage, and high spatiotemporal resolution [104]. Unlike CLSM, TPM utilizes a femtosecond, a near-infrared (680-1100 nm) laser, as its standard light source instead of the typical visible laser. In this case, only two-photon absorption can be formed at the focal plane. The outside of the focal plane is not excitable due to low intensity, reducing the light damage to this region. In this sense, TPM is sharper, as it is capable of reaching the submicron resolution when using two-photon excitation fluorescence microscopy (TPEFM) [105, 106].

PAT does not rely on ballistic or backscattered light, unlike OCT, DOT, and fluorescence tomography. As a result, the imaging depth in PAM is relatively large. The scattering of ultrasound signals by biotissues is 2 to 3 orders of magnitude lower than that of optical signals, so using it to reconstruct images can provide deeper imaging depth and higher spatial resolution. On the other hand, PAI indirectly carries out imaging based on the selective absorption of visible light, near-infrared light, or radio frequency electromagnetic waves by different tissues, which is not possible in pure conventional optical imaging. Light absorption by molecules creates a thermally induced pressure jump that launches ultrasonic waves, which are received with acoustic detectors to form images. Additionally, PAM has rich intrinsic and extrinsic optical contrasts and is free of speckle artifacts compared with USI [57].

Regardless of the imaging technology, the working wavelength used for detection is an important factor that affects imaging quality and depth. Whether it is a wide-field microscope or a confocal microscope, the full width at half maximum of the spot (airy disc), which determines the imaging resolution, is proportional to the incident wavelength [107].

5.2.2. Exploration of Imaging Enhancers

In addition to developing new imaging instruments and techniques, designing new imaging agents, such as fluorophores with better quantum yields, photostability, spectral properties, and biocompatibility, is the foremost approach to achieve deep tissue fluorescence imaging.

Undoubtedly, the improvement of efficient fluorophores and the use of multifunctional nanocarriers are important approaches to enhance fluorescence-dependent imaging and expand its applications. Similarly, the continuous development and ingenious use of various imaging contrast agents or optical clearing agents have played a key role in improving the efficacy of various imaging techniques. Therefore, when exploring how to improve the quality and capabilities of imaging techniques, the necessity of using appropriate imaging enhancers must be taken into consideration.

Given the important role of fluorescent contrast agents in TPM and tissue slices, confocal, fluorescence microscope, and live animal imaging, nanomaterials [108] including semiconductor quantum dots, metal nanoclusters, carbon nanomaterials, upconversion nanoparticles, and fluorescent silicon nanoparticles [55, 100, 109, 110], in addition to a variety of functionally different dyes, have been developed and used successively in the last decade. Fluorescent probes with high fluorescence quantum yields and high absorption coefficients are more desirable in the future [111].

Nanoparticles can increase circulation time and imaging brightness relative to single molecule imaging agent, which promotes the rapid development of nanocarriers for NIR imaging with long excitation and emission wavelengths. Additionally, it is important to choose the right fluorescent imaging agent in conjunction with the characteristics of materials used to construct MNAs, especially those fluorescent nanomaterials [109, 110] with increased mechanical properties of MNAs [112, 113] and various microenvironment-responsive fluorescent probes activated by redox, pH, hypoxic, enzyme, viscosity, ATP, and metal ions [111].

Contrast agents are equally important in OCT, USI, TPM, etc. They usually function as OCAs, called tissue optical clearing agents or skin optical clearing agents. Glycerol, glucose, poly(ethylene glycol) (PEG), dimethyl sulfoxide (DMSO), oleic acid, dextran, and some intravenous contrast agents are widely used in biological tissues [114]. PEG-400 can act as an OCA and significantly improved the photoacoustic amplitude for detection of deep-sealed blood vessels, while glycerol alone improved the image quality of shallow vessels. In contrast, DMSO application resulted in decreased photoacoustic amplitude in the in vivo trials [115].

When OCT is used, the depth of light penetration into highly scattered tissues can be improved by OCAs [116]. Studies have shown that glycerol enhances both OCT imaging depth and contrast [117], whereas DMSO only enhances penetration depth [114]. A mixture of fructose [118] or sucrose [119] with PEG-400 and thiazone was used as an OCA, has the optimal capacity of enhancing the OCT imaging performances, decreasing the scattering and the refractive index mismatching, and leads to an improved imaging performance for the deeper tissues. The imaging performance improvement is most likely caused by the OCA-induced dehydration of skin, and the reduction of scattering coefficient (more than ∼40.5%) and refractive index mismatching (more than ∼25.3%) in the superficial (epidermal, dermal, and hypodermal) layers [118].

Combining with OCAs, the imaging performances, including the imaging depth, resolution, contrast, and sensitivity of various optical imaging modalities, e.g., laser speckle contrast imaging, PAM, OCT, TPM, confocal (Raman) microscopy, etc., have been significantly enhanced [118]. Currently, a number of nanomaterials, including liposomes, polymers, micelles, dendrimers, emulsions, quantum dots, and solid nanoparticles have already been used as ultrasound contrast agents (UCA) [120]. In addition, the two-photon absorption properties can readily be improved just by increasing the loading content of aggregation-induced emission (AIE) fluorogen (AIEgen) [104].

5.3. Strategies for Appropriate Imaging Modalities

The imaging analysis of medical products like MNAs, whose sizes are between the macroscopic and mesoscopic scales of matter, is a challenge in terms of the balance and pursuit of resolution and detection depth. Various imaging techniques and devices with different detection depths, resolutions, and sensitivities can achieve different results and are used for different purposes to assess the effect of MNA penetration into the skin or mucosa (Figure 11). The development of OCT, CLSM, TPM, and micro-CT has paved the way for precise imaging-based evaluation of MNA penetration effects. Among them, CT utilizes electromagnetic radiation, which makes it unsuitable for in vivo imaging.

OCT and PAM can image in the millimeter depth range with the axial resolution to the micron level, filling the gap between USI and CLSM. OCT allows real-time imaging and is the most suitable imaging modality for observing the MNA puncture morphology thus far. Meanwhile, PAM is equally competitive in terms of imaging depth, spatial resolution, and speed for MNA evaluation.

Among the mesoscopic diffuse optical imaging techniques, laminar optical tomography (LOT) and spatial frequency domain imaging (SFDI) are well suited for skin characterization since they provide structural and functional information at relatively high spatial resolution (hundreds of microns) and depths of a few millimeters, Therefore, follow-up studies are necessary to elucidate their applications in evaluating MNA penetration quality [121].

In order to obtain a suitable imaging depth and resolution, it is necessary to comprehensively consider the light source parameters (bandwidth and wavelength) and the adaptation of the MNAs [122] (Figures 11 and 12). As shown in Table 2, there are significant differences in imaging depth and resolution among various OCT systems. The imaging depth is dependent on the maximum observable depth of MNA penetration. This depth is determined by the attenuation rates of components in the biological tissues and can be altered through tissue penetrants or refractive index matching fluids.

The resolution determines the clarity of MNA penetration imaging. The lateral resolution of OCT is actually the full width of the spot at the sample, and its best performance can only be achieved at the focal point. Improving the lateral resolution of OCT can be achieved by increasing the numerical aperture of the focusing mirror in the sample arm. However, an increase in lateral resolution means a reduction in the axial field of view, that is, a smaller depth of focus for the Gaussian beam. With the lateral scanning of the OCT, the defocusing phenomenon is more likely to occur. In this case, the sample far away from the zero optical path surface will be severely out of focus, reducing the efficiency of backscattered light collection [123]. The longitudinal resolution of the OCT can be approximated by the coherence length of the light source, which is inversely proportional to the bandwidth. Hence, the axial resolution of the OCT can be improved by increasing the bandwidth of the light source. However, increasing the light source bandwidth means the more serious the effect of dispersion. The main reason is the difference in dispersion characteristics caused by the different medium of the sample and reference arms. The strong dispersion in the system reduces the resolution, which is mainly determined by the bandwidth and the operating wavelength. Therefore, to compensate for this difference, it is necessary to add a dispersion medium to match the sample arm in the reference arm and subtract the additional phase from the postprocessing [124]. The axial resolution of OCT is inversely proportional to the bandwidth of the light source and proportional to the square of the central wavelength of the light source.

From the perspective of detection depth, more and more clinical diagnostic methods have shown considerable advantages. Garcia et al. [125] used Optovue OCT, Visaante OCT and ultrasonic thickness gauge to diagnose opaque cornea, and finally measured depths of 534.03 μm, 523.72 μm, and 529.84 μm, which were consistent with the study of MNA penetration depth. The study used a cornea that is very different from the skin tissue, but it provides an alternative method in terms of the detectable depth.

In OCT measurements of translucent materials, the speckle phenomenon that exists when analyzing depth signal attenuation to gain insight into tissue structure can cause attenuation coefficient images to contain unrealistic fluctuations, making these images less reliable at the voxel level. For this reason, Chang and Bowden [52] estimated the depth-resolved attenuation coefficient from OCT data with speckle, displayed it as an approximately exponential distribution, and finally solved the influence of speckle fluctuation on the depth-resolved recovery of OCT attenuation coefficient. Meanwhile, digital simulation techniques have been used by many researchers to overcome the limitations of OCT resolution, but their applicability is limited by the assumptions of the underlying deep analysis reconstruction technique.

Additionally, the confocal microscope, which is commonly used for skin diagnosis, has a very high resolution (about 1 μm) and a low penetration depth of about 250 μm. It can be connected to OCT clinically to form a line-field confocal optical coherence tomography (LC-OCT) [126], which has better cell resolution than OCT and higher penetration depth than CLSM. LC-OCT can be used to observe the skin surface to the deep dermis (approximately 500 μm) with a high spatial resolution (~1 μm), which is higher than the 5-7.5 μm resolution of ordinary OCT. Also, PAI, high-frequency ultrasound (HFUS), fluorescence Raman spectroscopy imaging, fluorescence lifetime microscopy (FLIM), Odyssey M multimode imaging analysis system, and other imaging technologies have shown increasing potential in the field of MNA penetration research.

Some technologies have been proposed to improve the axial resolution of TPM. Combined with the 4Pi technology, TPM can achieve submicron axial resolution but is restricted to transparent and thin biological samples, which makes it almost impossible to measure the structural and functional information from turbid samples in vivo. If combined with stimulated emission depletion (STED), TPM can break the diffraction limit in both the lateral and axial directions, and the spatial resolution is improved compared with the conventional TPM. Ye et al. [127] proposed a multiframe reconstruction two-photon microscopy (MR-TPM) with adaptive optics correction. This approach enables an almost threefold enhancement of the axial resolution relative to the conventional TPM. Gao et al. [128] developed a novel adaptive optics method for improving the quality of TPM. The method improved the lateral resolution from 1.27 μm to 0.75 μm and the axial resolution from 4 μm to 2 μm with more than a 5-fold increase in fluorescence signal intensity when imaging deep samples (1 mm). These studies altogether show the attractive prospect of TPM technology update.

When dual-band line-field CLSM is used, an imaging depth of ~700-800 μm can be achieved in the skin tissue [129]. The maximum depth of penetration of CLSM is also limited and is reported to be only 1.3 mm. Some scientists [130] developed a novel NIR-II mesoscopic system, which achieves the field of view (FOV) of , the lateral resolution of 6.3 μm, and the imaging depth up to 2.5 mm. With this system, single capillaries are clearly visible and are available to image 3D at large depths.

With its rich optical absorption contrast and high ultrasound scalability, PAT offers a comprehensive toolbox for life sciences that complements other imaging methods in terms of its contrast mechanism, spatiotemporal resolution, and penetration power. The strong acoustic attenuation and distortion of some biological tissues are a challenge for deep PAT [131], while the decrease in SNR (signal/noise ratio) in deep layers due to light and acoustic attenuation is another concern [132]. To solve this problem, a potential solution is to combine PAT with X-ray CT or other suitable modalities to obtain an accurate 3D model for acoustic correction. Just recently, Zhang et al. [133] developed a reflection-mode submicron-resolution PAM system. By imaging nanospheres and a resolution test chart, the lateral resolution was measured to be ∼0.5 μm with an optical wavelength of 532 nm and an optical numerical aperture of 0.63. The axial resolution was measured at 15 μm.

Although various imaging technologies have been continuously improved to meet the application needs, it is clear that any single method may have its limitations and cannot cope with all the complex demands of multiple objects and scenes. It has become an important trend to use multiple imaging technologies in a smart combination or multimodal imaging, so that the advantages of each complement each other and produce a synergistic optimization effect, in order to obtain the ideal sensitivity, spatial resolution, and imaging speed.

6. Conclusion and Outlook

MNAs are being investigated and applied in numerous fields as a convenient, rapid, and novel transdermal drug delivery system, but there is still no acceptable set of regulatory standards [16, 18, 19, 134]. It is necessary and urgent to establish a series of normative criteria and specifications for strict control of the effectiveness and quality of developed MNAs. The approval of the regulatory authorities of pharmaceutical preparations and medical devices is crucial for the safe and effective use of MNAs. Prior to obtaining the product marketing license, a systematic, scientific, and complete product quality control system must be established in accordance with GMP regulations. The imaging science based on the background of a variety of cutting-edge technologies, with the advantages of higher resolution and deeper imaging depth, helps to objectively evaluate the penetration behavior of MNAs both ex vivo and in vivo, thereby developing a comprehensive characterization and evaluation system.

On the other hand, the shift of MNA manufacturing from laboratory assembly to industrial mass production will generate related monitoring and analysis technologies, including imaging technologies, required for MNA manufacturing and quality control in terms of accessibility, operability, reliability, and applicability to multiple scenarios. Taking OCT technology as an example, the main trends are currently focused on large-range imaging, high-speed imaging, etc., which partially meet the needs. Large-range imaging means that the depth of MNA penetration can be probed more precisely, and high-speed imaging makes it possible that real-time video imaging analysis of the process of MNA penetration and the change of the pore channel after extraction. Currently, OCT large-range imaging is mainly used to increase the axial depth by suppressing the conjugate mirror [135, 136] and increasing the spectrometer resolution [137, 138], while OCT high-speed imaging techniques can be briefly grouped into two categories, one relying mainly on increasing the line scan frequency of the line array camera or introducing a high-speed scanning light source and the other by modifying the imaging strategy including setting up multiple line array cameras in the spectrometer and acquiring spectra alternately to achieve an exponential increase in imaging speed [19, 139, 140].

Regardless of the skin models used, either animal skin that similar to human skin or artificial skin manufactured based on real skin parameters [19], the relationship between the imaging mode and the calculation model is often involved in the study of MNAs. Noninvasive imaging methods for real skin punctured by MNAs, tomographic reconstruction techniques like OCT or CT, are currently only in the depth measurement after three-dimensional reconstruction or observation of the overall penetration state. In this sense, the acquisition of insertion depth data is only the analysis and characterization of two-dimensional images. There is a certain overlap between the dermatology imaging technology used in clinical medicine and the imaging technology used for MNA penetration effect, such as OCT, CLSM, TPM, PAT, and USI, so that the development and progress of these technologies are of great significance to the depth or volume of MNA insertion. Achieving precise distinction of subtle differences in the measured subject is not only a matter of imaging technology itself but also a goal to be pursued in precision medicine research at the cellular and human levels.

By accurately analyzing the volume of the MNAs inserted into the body, it provides a more accurate reflection of the total amount of drug in the MNAs delivered into the body than merely observing the insertion length. The exploration of 3D imaging of MNA penetration is still under investigation, but the quantitative analysis methods for MNA loading drugs into the body including high-performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS), gas chromatography-mass spectrometry (GC-MS), and other chromatographic techniques are now widely available and can be easily accessed for utilization. The evaluation of the penetration amount and penetration depth is of great importance for the mechanical properties of the prepared MNAs, drug loading, and other issues. In addition, precision medicine requires higher resolution for fluorescence-based or isotope-labeled imaging techniques to make cellular or subcellular level judgments to study the in vivo distribution of drugs in MNAs [3, 4, 11, 141]. All in all, the characterization and clinical application of MNAs need a multidimensional study. The drug capacity, diffusion rate, penetration efficiency, and fracture force of MNAs are all difficult to characterize only with imaging techniques. It will be an inevitable trend to combine technologies from many fields, including imaging, to evaluate the quality and in vivo pharmacokinetics of MNAs. Simultaneously, the field of imaging technology can also benefit from this unique application, giving rise to new methods or technical improvements.

Conflicts of Interest

All of the authors declare that they have no conflict of interest or financial conflicts to disclose.

Authors’ Contributions

Fengsen Ma, Yilong Zhang, Yen Wei, and Mei Tian conceived and supervised the overall project. Yanni Wang and Gehua Ma initiated the idea, searched and collected the literature, performed the graphic and table design, and wrote the manuscript. Guangzhi Gao, Ji Tao, Wenzhao Cao, and Haohao Sun wrote the manuscript and contributed to discussions. Yanni Wang and Gehua Ma contributed equally to this work.


We thank Yuan Wang for her valuable discussion. This work was supported in part by the National Natural Science Foundation of China under Grant No. 21788102, 81725009, 61527808, and 61905218.


  1. A. H. Sabri, Y. Kim, M. Marlow et al., “Intradermal and transdermal drug delivery using microneedles - fabrication, performance evaluation and application to lymphatic delivery,” Advanced Drug Delivery Reviews, vol. 153, pp. 195–215, 2020. View at: Publisher Site | Google Scholar
  2. X. Zhang, Y. Wang, J. Chi, and Y. Zhao, “Smart microneedles for therapy and diagnosis,” Research, vol. 2020, article 7462915, 26 pages, 2020. View at: Publisher Site | Google Scholar
  3. C. Li and M. Tian, Drug delivery applications of noninvasive imaging, John Wiley & Sons, 2013. View at: Publisher Site
  4. J. Zhang, Q. He, Z. K. Wu, B. Yu, J. L. Qu, and D. Y. Lin, “Application and development of super-resolution microscopy in live cell imaging,” Progress in Biochemistry and Biophysics, vol. 48, no. 11, pp. 1301–1315, 2021. View at: Publisher Site | Google Scholar
  5. K. Zhang, Y. Sun, S. Wu et al., “Systematic imaging in medicine: a comprehensive review,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 6, pp. 1736–1758, 2020. View at: Publisher Site | Google Scholar
  6. G. Arrabito, S. Reisewitz, L. Dehmelt et al., “Biochips for cell biology by combined dip-pen nanolithography and DNA-directed protein immobilization,” Small, vol. 9, no. 24, pp. 4243–4249, 2013. View at: Publisher Site | Google Scholar
  7. F. Ricci, R. Y. Lai, A. J. Heeger, K. W. Plaxco, and J. J. Sumner, “Effect of molecular crowding on the response of an electrochemical DNA sensor,” Langmuir, vol. 23, no. 12, pp. 6827–6834, 2007. View at: Publisher Site | Google Scholar
  8. W. L. Ng, M. H. Goh, W. Y. Yeong, and M. W. Naing, “Applying macromolecular crowding to 3d bioprinting: fabrication of 3d hierarchical porous collagen-based hydrogel constructs,” Biomaterials Science, vol. 6, no. 3, pp. 562–574, 2018. View at: Publisher Site | Google Scholar
  9. A. P. Ajay, A. DasGupta, and D. Chatterjee, “Fabrication of monolithic SU-8 microneedle arrays having different needle geometries using a simplified process,” The International Journal of Advanced Manufacturing Technology, vol. 114, no. 11-12, pp. 3615–3626, 2021. View at: Publisher Site | Google Scholar
  10. L. Tang, C. Y. Zhao, X. H. Wang et al., “Macromolecular crowding of molecular imprinting: a facile pathway to produce drug delivery devices for zero-order sustained release,” International Journal of Pharmaceutics, vol. 496, no. 2, pp. 822–833, 2015. View at: Publisher Site | Google Scholar
  11. M. Tian, X. X. He, C. T. Jin et al., “Transpathology: molecular imaging-based pathology,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 8, pp. 2338–2350, 2021. View at: Publisher Site | Google Scholar
  12. P. Makvandi, M. Kirkby, A. R. J. Hutton et al., “Engineering microneedle patches for improved penetration: analysis, skin models and factors affecting needle insertion,” Nano-Micro Letters, vol. 13, no. 1, p. 93, 2021. View at: Publisher Site | Google Scholar
  13. L. Yang, Y. Yang, H. Chen, L. Mei, and X. Zeng, “Polymeric microneedle-mediated sustained release systems: Design strategies and promising applications for drug delivery,” Asian Journal of Pharmaceutical Sciences, vol. 17, no. 1, pp. 70–86, 2022. View at: Publisher Site | Google Scholar
  14. P. Singh, A. Carrier, Y. Chen et al., “Polymeric microneedles for controlled transdermal drug delivery,” Journal of Controlled Release, vol. 315, pp. 97–113, 2019. View at: Publisher Site | Google Scholar
  15. J. Zhang, F. S. Ma, H. H. Zhan, and Y. C. Huang, “Matrix materials and their composites for dissolvable microneedle construction: a review,” Materials Reports, vol. 31, no. 19, pp. 129–134, 2017. View at: Publisher Site | Google Scholar
  16. R. R. Li, Y. Wang, Y. Liu, Y. N. Wang, Z. Liu, and F. S. Ma, “Effects of metal or dissolving microneedles and its parameters of operation on the formation and closure of skin microchannels,” Acta Pharmaceutica Sinica B, vol. 56, no. 4, pp. 1163–1169, 2021. View at: Publisher Site | Google Scholar
  17. H. H. Zhan, Y. C. Huang, and F. S. Ma, “Research progress in the evaluation method of microneedle puncture performance,” Chinese Pharmaceutical Journal, vol. 53, no. 22, pp. 1890–1895, 2018. View at: Publisher Site | Google Scholar
  18. R. R. Li, Y. Wang, Z. Liu et al., “Influencing factors and evaluation methods of skin microchannels formation and closure after microneedles application,” Acta Pharmaceutica Sinica B, vol. 56, no. 5, pp. 1293–1300, 2021. View at: Publisher Site | Google Scholar
  19. Y. Wang, F. S. Ma, Y. N. Wang et al., “Skin models and its related evaluation of microneedle puncture performance,” Progress in Biochemistry and Biophysics, vol. 49, no. 8, pp. 1–23, 2022. View at: Google Scholar
  20. H. H. Sun, Y. L. Zhang, P. Chen, H. Wan, and R. Liang, “Synchronous fingerprint acquisition system based on total internal reflection and optical coherence tomography,” IEEE Transactions on Instrumentation and Measurement, vol. 69, no. 10, pp. 8452–8465, 2020. View at: Publisher Site | Google Scholar
  21. Y. Yu, H. X. Wang, H. H. Sun, Y. L. Zhang, P. Chen, and R. H. Liang, “Optical coherence tomography in fingertip biometrics,” Optics and Lasers in Engineering, vol. 151, 2022. View at: Publisher Site | Google Scholar
  22. M. C. Chen, Z. W. Lin, and M. H. Ling, “Near-infrared light-activatable microneedle system for treating superficial tumors by combination of chemotherapy and photothermal therapy,” ACS Nano, vol. 10, no. 1, pp. 93–101, 2016. View at: Publisher Site | Google Scholar
  23. V. Zvezdin, L. Peno-Mazzarino, N. Radionov, T. Kasatkina, and I. Kasatkin, “Microneedle patch based on dissolving, detachable microneedle technology for improved skin quality – part 1: ex vivo safety evaluation,” International Journal of Cosmetic Science, vol. 42, no. 4, pp. 369–376, 2020. View at: Publisher Site | Google Scholar
  24. M. Avcil, G. Akman, J. Klokkers, D. Jeong, and A. Celik, “Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: a monocentric clinical study,” Journal of Cosmetic Dermatology, vol. 19, no. 2, pp. 328–337, 2020. View at: Publisher Site | Google Scholar
  25. M. Jang, S. Baek, G. Kang, H. Yang, S. Kim, and H. Jung, “Dissolving microneedle with high molecular weight hyaluronic acid to improve skin wrinkles, dermal density and elasticity,” International Journal of Cosmetic Science, vol. 42, no. 3, pp. 302–309, 2020. View at: Publisher Site | Google Scholar
  26. R. F. Donnelly, R. Majithiya, T. R. Singh et al., “Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique,” Pharmaceutical Research, vol. 28, no. 1, pp. 41–57, 2011. View at: Publisher Site | Google Scholar
  27. W. J. Yu, G. H. Jiang, Y. Zhang, D. P. Liu, B. Xu, and J. Y. Zhou, “Near-infrared light triggered and separable microneedles for transdermal delivery of metformin in diabetic rats,” Journal of Materials Chemistry B, vol. 5, no. 48, pp. 9507–9513, 2017. View at: Publisher Site | Google Scholar
  28. S. Bhatnagar, N. G. Bankar, M. V. Kulkarni, and V. V. K. Venuganti, “Dissolvable microneedle patch containing doxorubicin and docetaxel is effective in 4T1 xenografted breast cancer mouse model,” International Journal of Pharmaceutics, vol. 556, pp. 263–275, 2019. View at: Publisher Site | Google Scholar
  29. Y. Wu, L. K. Vora, Y. Wang et al., “Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 165, pp. 306–318, 2021. View at: Publisher Site | Google Scholar
  30. E. Larraneta, J. Moore, E. M. Vicente-Perez et al., “A proposed model membrane and test method for microneedle insertion studies,” International Journal of Pharmaceutics, vol. 472, no. 1-2, pp. 65–73, 2014. View at: Publisher Site | Google Scholar
  31. A. S. Cordeiro, I. A. Tekko, M. H. Jomaa et al., “Two-photon polymerisation 3d printing of microneedle array templates with versatile designs: application in the development of polymeric drug delivery systems,” Pharmaceutical Research, vol. 37, no. 9, p. 174, 2020. View at: Publisher Site | Google Scholar
  32. A. H. Sabri, Z. Cater, P. Gurnani et al., “Intradermal delivery of imiquimod using polymeric microneedles for basal cell carcinoma,” International Journal of Pharmaceutics, vol. 589, article 119808, 2020. View at: Publisher Site | Google Scholar
  33. H. X. Nguyen and A. K. Banga, “Delivery of methotrexate and characterization of skin treated by fabricated PLGA microneedles and fractional ablative laser,” Pharmaceutical Research, vol. 35, no. 3, p. 68, 2018. View at: Publisher Site | Google Scholar
  34. V. Leeladurga, U. C. Teja, S. K. Sultana et al., “Application of microneedle arrays for enhancement of transdermal permeation of insulin: In vitro experiments, scaling analyses and numerical simulations,” AAPS Pharm Sci Tech, vol. 17, no. 4, pp. 915–922, 2016. View at: Publisher Site | Google Scholar
  35. L. Y. Chu and M. R. Prausnitz, “Separable arrowhead microneedles,” Journal of Controlled Release, vol. 149, no. 3, pp. 242–249, 2011. View at: Publisher Site | Google Scholar
  36. Y. H. Park, S. K. Ha, I. Choi et al., “Fabrication of degradable carboxymethyl cellulose (cmc) microneedle with laser writing and replica molding process for enhancement of transdermal drug delivery,” Biotechnol Bioproc E, vol. 21, no. 1, pp. 110–118, 2016. View at: Publisher Site | Google Scholar
  37. A. Rana, A. Lowe, M. Lithgow et al., “Use of deep learning to develop and analyze computational hematoxylin and eosin staining of prostate core biopsy images for tumor diagnosis,” JAMA Network Open, vol. 3, no. 5, article e205111, 2020. View at: Publisher Site | Google Scholar
  38. B. S. Restall, N. J. M. Haven, P. Kedarisetti et al., “Virtual hematoxylin and eosin histopathology using simultaneous photoacoustic remote sensing and scattering microscopy,” Optics Express, vol. 29, no. 9, 2021. View at: Publisher Site | Google Scholar
  39. W. Li, Z. Zhou, and Y. Li, “Inspection of butt welds for complex surface parts using ultrasonic phased array,” Ultrasonics, vol. 96, pp. 75–82, 2019. View at: Publisher Site | Google Scholar
  40. X. X. Qu, Y. Song, Y. H. Zhang, and H. M. Qing, “Value of ultrasonic elastography and conventional ultrasonography in the differential diagnosis of non-mass-like breast lesions,” Ultrasound in Medicine & Biology, vol. 45, no. 6, pp. 1358–1366, 2019. View at: Publisher Site | Google Scholar
  41. B. C. Seah and B. M. Teo, “Recent advances in ultrasound-based transdermal drug delivery,” International Journal of Nanomedicine, vol. 13, pp. 7749–7763, 2018. View at: Publisher Site | Google Scholar
  42. C. Wu, J. Cheng, W. Li, L. Yang, H. Dong, and X. Zhang, “Programmable polymeric microneedles for combined chemotherapy and antioxidative treatment of rheumatoid arthritis,” ACS Applied Materials & Interfaces, vol. 13, no. 46, pp. 55559–55568, 2021. View at: Publisher Site | Google Scholar
  43. H. Zhang, H. B. Zhao, X. Y. Zhao et al., “Biocompatible light guide-assisted wearable devices for enhanced uv light delivery in deep skin,” Advanced Functional Materials, vol. 31, no. 23, article 2100576, 2021. View at: Publisher Site | Google Scholar
  44. L. B. Liu, Q. Q. Wang, H. W. Liao et al., “Soluble microneedle patch with photothermal and no-release properties for painless and precise treatment of ischemic perforator flaps,” Journal of Materials Chemistry B, vol. 9, no. 37, pp. 7725–7733, 2021. View at: Publisher Site | Google Scholar
  45. A. Vrdoljak, E. A. Allen, F. Ferrara, N. J. Temperton, A. M. Crean, and A. C. Moore, “Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods,” Journal of Controlled Release, vol. 225, pp. 192–204, 2016. View at: Publisher Site | Google Scholar
  46. J. Monkare, M. Reza Nejadnik, K. Baccouche, S. Romeijn, W. Jiskoot, and J. A. Bouwstra, “Igg-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery,” Journal of Controlled Release, vol. 218, pp. 53–62, 2015. View at: Publisher Site | Google Scholar
  47. F. Helmchen and W. Denk, “Deep tissue two-photon microscopy,” Nature Methods, vol. 2, no. 12, pp. 932–940, 2005. View at: Publisher Site | Google Scholar
  48. P. T. C. So, C. Y. Dong, B. R. Masters, and K. M. Berland, “Two-photon excitation fluorescence microscopy,” Annual Review of Biomedical Engineering, vol. 2, no. 1, pp. 399–429, 2000. View at: Publisher Site | Google Scholar
  49. S. D. Gittard, P. R. Miller, R. D. Boehm et al., “Multiphoton microscopy of transdermal quantum dot delivery using two photon polymerization-fabricated polymer microneedles,” Faraday Discussions, vol. 149, pp. 171–185, 2011. View at: Publisher Site | Google Scholar
  50. W. S. Chiu, N. A. Belsey, N. L. Garrett et al., “Drug delivery into microneedle-porated nails from nanoparticle reservoirs,” Journal of Controlled Release, vol. 220, no. Part A, pp. 98–106, 2015. View at: Publisher Site | Google Scholar
  51. T. Rattanapak, J. Birchall, K. Young et al., “Transcutaneous immunization using microneedles and cubosomes: mechanistic investigations using optical coherence tomography and two-photon microscopy,” Journal of Controlled Release, vol. 172, no. 3, pp. 894–903, 2013. View at: Publisher Site | Google Scholar
  52. S. Chang and A. K. Bowden, “Review of methods and applications of attenuation coefficient measurements with optical coherence tomography,” Journal of Biomedical Optics, vol. 24, no. 9, pp. 1–17, 2019. View at: Publisher Site | Google Scholar
  53. J. G. Fujimoto, D. L. Farkas, and B. R. Masters, “Biomedical optical imaging,” Journal of Biomedical Optics, vol. 15, no. 5, article 059902, 2007. View at: Publisher Site | Google Scholar
  54. Z. Wang, F. Yang, H. Ma et al., “Bifocal 532/1064 nm alternately illuminated photoacoustic microscopy for capturing deep vascular morphology in human skin,” Journal of the European Academy of Dermatology and Venereology, vol. 36, no. 1, pp. 51–59, 2022. View at: Publisher Site | Google Scholar
  55. Q. Fu, R. Zhu, J. Song, H. Yang, and X. Chen, “Photoacoustic imaging: contrast agents and their biomedical applications,” Advanced Materials, vol. 31, no. 6, article 1805875, 2018. View at: Publisher Site | Google Scholar
  56. L. V. Wang and S. Hu, “Photoacoustic tomography: in vivo imaging from organelles to organs,” Science, vol. 335, no. 6075, pp. 1458–1462, 2012. View at: Publisher Site | Google Scholar
  57. M. Moothanchery, R. Z. Seeni, C. Xu, and M. Pramanik, “In vivo studies of transdermal nanoparticle delivery with microneedles using photoacoustic microscopy,” Biomedical Optics Express, vol. 8, no. 12, p. 5483, 2017. View at: Publisher Site | Google Scholar
  58. T. Ilovitsh, A. Ilovitsh, J. Foiret, B. Z. Fite, and K. W. Ferrara, “Acoustical structured illumination for super-resolution ultrasound imaging,” Communications Biology, vol. 1, no. 1, 2018. View at: Publisher Site | Google Scholar
  59. T. Hinsdale, C. Olsovsky, J. J. Rico-Jimenez, K. C. Maitland, J. A. Jo, and B. H. Malik, “Optically sectioned wide-field fluorescence lifetime imaging microscopy enabled by structured illumination,” Biomedical Optics Express, vol. 8, no. 3, pp. 1455–1465, 2017. View at: Publisher Site | Google Scholar
  60. M. Rajadhyaksha, S. González, J. M. Zavislan, R. Rox Anderson, and R. H. Webb, “In vivo confocal scanning laser microscopy of human skin ii: advances in instrumentation and comparison with histology,” Journal of Investigative Dermatology, vol. 113, no. 3, pp. 293–303, 1999. View at: Publisher Site | Google Scholar
  61. H. X. Nguyen, B. D. Bozorg, Y. Kim et al., “Poly (vinyl alcohol) microneedles: fabrication, characterization, and application for transdermal drug delivery of doxorubicin,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 129, pp. 88–103, 2018. View at: Publisher Site | Google Scholar
  62. M. Rajadhyaksha, M. Grossman, D. Esterowitz, R. H. Webb, and R. Rox Anderson, “In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast,” Journal of Investigative Dermatology, vol. 104, no. 6, pp. 946–952, 1995. View at: Publisher Site | Google Scholar
  63. W. Yu, G. Jiang, Y. Zhang, D. Liu, B. Xu, and J. Zhou, “Polymer microneedles fabricated from alginate and hyaluronate for transdermal delivery of insulin,” Materials Science and Engineering: C, vol. 80, pp. 187–196, 2017. View at: Publisher Site | Google Scholar
  64. J. B. Pawley, Handbook of biological confocal microscopy, Plenum Press, 1990. View at: Publisher Site
  65. W. J. Yu, G. H. Jiang, D. P. Liu et al., “Fabrication of biodegradable composite microneedles based on calcium sulfate and gelatin for transdermal delivery of insulin,” Materials Science and Engineering: C, vol. 71, pp. 725–734, 2017. View at: Publisher Site | Google Scholar
  66. K. Y. Yu, X. M. Yu, S. S. Cao et al., “Layered dissolving microneedles as a need-based delivery system to simultaneously alleviate skin and joint lesions in psoriatic arthritis,” Acta Pharmaceutica Sinica B, vol. 11, no. 2, pp. 505–519, 2021. View at: Publisher Site | Google Scholar
  67. Y. Kim, S. A. Bhattaccharjee, M. Beck-Broichsitter, and A. K. Banga, “Fabrication and characterization of hyaluronic acid microneedles to enhance delivery of magnesium ascorbyl phosphate into skin,” Biomedical Microdevices, vol. 21, no. 4, p. 104, 2019. View at: Publisher Site | Google Scholar
  68. A. Panda, P. K. Sharma, T. McCann, J. Bloomekatz, M. A. Repka, and S. N. Murthy, “Fabrication and development of controlled release PLGA microneedles for macromolecular delivery using fitc-dextran as model molecule,” Journal of Drug Delivery Science and Technology, vol. 68, article 102712, 2022. View at: Publisher Site | Google Scholar
  69. J. Enfield, M. L. O’Connell, K. Lawlor, E. Jonathan, C. O’Mahony, and M. Leahy, “In-vivo dynamic characterization of microneedle skin penetration using optical coherence tomography,” Journal of Biomedical Optics, vol. 15, no. 4, article 046001, 2010. View at: Publisher Site | Google Scholar
  70. S. O'Leary, A. Fotouhi, D. Turk et al., “Oct image atlas of healthy skin on sun-exposed areas,” Skin Research and Technology, vol. 24, no. 4, pp. 570–586, 2018. View at: Publisher Site | Google Scholar
  71. J. Welzel, “Optical coherence tomography in dermatology: a review,” Skin Research and Technology, vol. 7, no. 1, pp. 1–9, 2001. View at: Publisher Site | Google Scholar
  72. R. R. S. Thakur, I. A. Tekko, F. Al-Shammari, A. A. Ali, H. McCarthy, and R. F. Donnelly, “Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery,” Drug Delivery and Translational Research, vol. 6, no. 6, pp. 800–815, 2016. View at: Publisher Site | Google Scholar
  73. E. Z. Loizidou, N. T. Inoue, J. Ashton-Barnett, D. A. Barrow, and C. J. Allender, “Evaluation of geometrical effects of microneedles on skin penetration by ct scan and finite element analysis,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 107, 2016. View at: Publisher Site | Google Scholar
  74. R. Liu, M. Zhang, and C. Jin, “In vivo and in situ imaging of controlled-release dissolving silk microneedles into the skin by optical coherence tomography,” Journal of Biophotonics, vol. 10, no. 6-7, pp. 870–877, 2017. View at: Publisher Site | Google Scholar
  75. R. F. Donnelly, M. J. Garland, D. I. Morrow et al., “Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution,” Journal of Controlled Release, vol. 147, no. 3, pp. 333–341, 2010. View at: Publisher Site | Google Scholar
  76. A. Abramson, E. Caffarel-Salvador, V. Soares et al., “A luminal unfolding microneedle injector for oral delivery of macromolecules,” Nature Medicine, vol. 25, no. 10, pp. 1512–1518, 2019. View at: Publisher Site | Google Scholar
  77. L. K. Vora, R. F. Donnelly, E. Larrañeta, P. González-Vázquez, R. R. S. Thakur, and P. R. Vavia, “Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: proof of concept,” Journal of Controlled Release, vol. 265, pp. 93–101, 2017. View at: Publisher Site | Google Scholar
  78. W. Qin, G. Quan, Y. Sun et al., “Dissolving microneedles with spatiotemporally controlled pulsatile release nanosystem for synergistic chemo-photothermal therapy of melanoma,” Theranostics., vol. 10, no. 18, pp. 8179–8196, 2020. View at: Publisher Site | Google Scholar
  79. B. Limcharoen, P. Toprangkobsin, M. Kroger et al., “Microneedle-facilitated intradermal proretinal nanoparticle delivery,” Nanomaterials, vol. 10, no. 2, 2020. View at: Publisher Site | Google Scholar
  80. I. C. Lee, W. M. Lin, J. C. Shu, S. W. Tsai, C. H. Chen, and M. T. Tsai, “Formulation of two-layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice,” Journal of Biomedical Materials Research. Part A, vol. 105, no. 1, pp. 84–93, 2017. View at: Publisher Site | Google Scholar
  81. E. M. Vicente-Perez, H. L. Quinn, E. McAlister et al., “The use of a pressure-indicating sensor film to provide feedback upon hydrogel-forming microneedle array self-application in vivo,” Pharmaceutical Research, vol. 33, no. 12, pp. 3072–3080, 2016. View at: Publisher Site | Google Scholar
  82. M. T. Tsai, I. C. Lee, Z. F. Lee et al., “In vivo investigation of temporal effects and drug delivery induced by transdermal microneedles with optical coherence tomography,” Biomedical Optics Express, vol. 7, no. 5, pp. 1865–1876, 2016. View at: Publisher Site | Google Scholar
  83. J. J. Cheng, H. W. Pan, C. L. Chen, T. Jin, Y. Dong, and J. Y. Chen, “Two-stage lesion detection approach based on dimension-decomposition and 3d context,” Tsinghua Science and Technology, vol. 27, no. 1, pp. 103–113, 2022. View at: Publisher Site | Google Scholar
  84. M. S. Irie, G. D. Rabelo, R. Spin-Neto, P. Dechichi, J. S. Borges, and P. B. F. Soares, “Use of micro-computed tomography for bone evaluation in dentistry,” Brazilian Dental Journal, vol. 29, no. 3, pp. 227–238, 2018. View at: Publisher Site | Google Scholar
  85. K. J. Lee, S. S. Jeong, D. H. Roh, D. Y. Kim, H. K. Choi, and E. H. Lee, “A practical guide to the development of microneedle systems - in clinical trials or on the market,” International Journal of Pharmaceutics, vol. 573, article 118778, 2020. View at: Publisher Site | Google Scholar
  86. X. Zhao, X. F. Li, P. Zhang, J. W. Du, and Y. X. Wang, “Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor,” Journal of Controlled Release, vol. 286, pp. 201–209, 2018. View at: Publisher Site | Google Scholar
  87. C. Edens, N. C. Dybdahl-Sissoko, W. C. Weldon, M. S. Oberste, and M. R. Prausnitz, “Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque,” Vaccine, vol. 33, no. 37, pp. 4683–4690, 2015. View at: Publisher Site | Google Scholar
  88. D. A. Castilla-Casadiego, H. Carlton, D. Gonzalez-Nino et al., “Design, characterization, and modeling of a chitosan microneedle patch for transdermal delivery of meloxicam as a pain management strategy for use in cattle,” Materials Science and Engineering: C, vol. 118, article 111544, 2021. View at: Publisher Site | Google Scholar
  89. M. C. Chen, M. H. Ling, K. Y. Lai, and E. Pramudityo, “Chitosan microneedle patches for sustained transdermal delivery of macromolecules,” Biomacromolecules, vol. 13, no. 12, pp. 4022–4031, 2012. View at: Publisher Site | Google Scholar
  90. D. Ando, T. Miyazaki, E. Yamamoto, T. Koide, and K. I. Izutsu, “Chemical imaging analysis of active pharmaceutical ingredient in dissolving microneedle arrays by raman spectroscopy,” Drug Delivery and Translational Research, vol. 12, no. 2, pp. 426–434, 2022. View at: Publisher Site | Google Scholar
  91. X. M. Lan, J. C. She, D. Lin et al., “Microneedle-mediated delivery of lipid-coated cisplatin nanoparticles for efficient and safe cancer therapy,” ACS Applied Materials & Interfaces, vol. 10, no. 39, pp. 33060–33069, 2018. View at: Publisher Site | Google Scholar
  92. X. X. Zhang, X. Fu, G. P. Chen, Y. T. Wang, and Y. J. Zhao, “Versatile ice microneedles for transdermal delivery of diverse actives,” Advanced Science, vol. 8, no. 17, article e2101210, 2021. View at: Publisher Site | Google Scholar
  93. Y. Hao, Y. Chen, X. He et al., “Near-infrared responsive 5-fluorouracil and indocyanine green loaded mpeg-pcl nanoparticle integrated with dissolvable microneedle for skin cancer therapy,” Bioact Mater., vol. 5, no. 3, pp. 542–552, 2020. View at: Publisher Site | Google Scholar
  94. C. E. O'Connell-Rodwell, S. M. Burns, M. H. Bachmann, and C. H. Contag, “Bioluminescent indicators for in vivo measurements of gene expression,” Trends in Biotechnology, vol. 20, no. 8, pp. S19–S23, 2002. View at: Publisher Site | Google Scholar
  95. Y. Lv, J. Tian, W. Cong et al., “A multilevel adaptive finite element algorithm for bioluminescence tomography,” Optics Express, vol. 14, no. 18, pp. 8211–8223, 2006. View at: Publisher Site | Google Scholar
  96. G. Kang, T. N. T. Tu, S. Kim et al., “Adenosine-loaded dissolving microneedle patches to improve skin wrinkles, dermal density, elasticity and hydration,” International Journal of Cosmetic Science, vol. 40, no. 2, pp. 199–206, 2018. View at: Publisher Site | Google Scholar
  97. B. Hassan, S. Qin, T. Hassan, R. Ahmed, and N. Werghi, “Joint segmentation and quantification of chorioretinal biomarkers in optical coherence tomography scans: a deep learning approach,” IEEE Transactions on Instrumentation and Measurement, vol. 70, 2021. View at: Publisher Site | Google Scholar
  98. G. Selvaggio, M. Weitzel, N. Oleksiievets et al., “Photophysical properties and fluorescence lifetime imaging of exfoliated near-infrared fluorescent silicate nanosheets,” Nanoscale Advances, vol. 3, no. 15, pp. 4541–4553, 2021. View at: Publisher Site | Google Scholar
  99. L. Sun, L. Fan, F. Bian, G. Chen, Y. Wang, and Y. Zhao, “Mxene-integrated microneedle patches with innate molecule encapsulation for wound healing,” Research, vol. 2021, article 9838490, 9 pages, 2021. View at: Publisher Site | Google Scholar
  100. G. S. Hong, S. Diao, A. L. Antaris, and H. Dai, “Carbon nanomaterials for biological imaging and nanomedicinal therapy,” Chemical Reviews, vol. 115, no. 19, pp. 10816–10906, 2015. View at: Publisher Site | Google Scholar
  101. C. E. Psomadakis, N. Marghoob, B. Bleicher, and O. Markowitz, “Optical coherence tomography,” Clinics in Dermatology, vol. 39, no. 4, pp. 624–634, 2021. View at: Publisher Site | Google Scholar
  102. M. B. Dürrenberger, S. Handschin, B. Conde-Petit, and F. Escher, “Visualization of food structure by confocal laser scanning microscopy (clsm),” LWT - Food Science and Technology, vol. 34, no. 1, pp. 11–17, 2001. View at: Publisher Site | Google Scholar
  103. Y. Chen, H. Guo, W. Gong et al., “Recent advances in two-photon imaging: technology developments and biomedical applications,” Chinese Optics Letters, vol. 11, no. 1, pp. 59–66, 2013. View at: Publisher Site | Google Scholar
  104. Y. Dou, Q. Zhu, and K. Du, “Recent advances in two-photon aiegens and their application in biological systems,” Chem Bio Chem, vol. 22, no. 11, p. 1871, 2021. View at: Publisher Site | Google Scholar
  105. S. W. Perry, R. M. Burke, and E. B. Brown, “Two-photon and second harmonic microscopy in clinical and translational cancer research,” Annals of Biomedical Engineering, vol. 40, no. 2, pp. 277–291, 2012. View at: Publisher Site | Google Scholar
  106. A. K. Hadjantonakis, M. E. Dickinson, S. E. Fraser, and V. E. Papaioannou, “Technicolour transgenics: imaging tools for functional genomics in the mouse,” Nature Reviews Genetics, vol. 4, no. 8, pp. 613–625, 2003. View at: Publisher Site | Google Scholar
  107. L. Zhijian, W. Yaqiong, and C. Liangyi, “Introduction to theories of several super-resolution fluorescence microscopy methods and recent advance in the field,” Progress in Biochemistry and Biophysics, vol. 36, no. 12, pp. 1626–1634, 2009. View at: Publisher Site | Google Scholar
  108. R. Borlan, M. Focsan, D. Maniu, and S. Astilean, “Interventional NIR fluorescence imaging of cancer: review on next generation of dye-loaded protein-based nanoparticles for real-time feedback during cancer surgery,” International Journal of Nanomedicine, vol. 16, pp. 2147–2171, 2021. View at: Publisher Site | Google Scholar
  109. D. Zhao, C. T. Wang, L. Su, and X. J. Zhang, “Application of fluorescen nanomaterials in pathogenic bacteria detection,” Progress in Chemistry, vol. 33, no. 9, pp. 1482–1495, 2021. View at: Publisher Site | Google Scholar
  110. S. G. He, J. Song, J. L. Qu, and Z. Cheng, “Crucial breakthrough of second near-infrared biological window fluorophores: design and synthesis toward multimodal imaging and theranostics,” Chemical Society Reviews, vol. 47, no. 12, pp. 4258–4278, 2018. View at: Publisher Site | Google Scholar
  111. C. Sun, B. Q. Wang, B. Dong et al., “Review—advances in the application of microenvironment-responsive NIR-II fluorescent probes in organisms,” ECS Journal of Solid State Science and Technology, vol. 10, no. 7, article 076002, 2021. View at: Publisher Site | Google Scholar
  112. Y. Y. Bao, Z. Liu, Y. Liu, and F. S. Ma, “Preparation and characterization of dissolving microneedles with nano-enhanced mechanical properties,” Acta Pharmaceutica Sinica B, vol. 56, no. 7, 2021. View at: Publisher Site | Google Scholar
  113. X. L. Hu, H. J. Zhang, Z. J. Wang, C. Y. A. Shiu, and Z. Gu, “Microneedle array patches integrated with nanoparticles for therapy and diagnosis,” Small Structures, vol. 2, no. 4, article 2000097, 2021. View at: Publisher Site | Google Scholar
  114. Y. H. He and R. K. Wang, “Dynamic optical clearing effect of tissue impregnated with hyperosmotic agents and studied with optical coherence tomography,” Journal of Biomedical Optics, vol. 9, no. 1, 2004. View at: Publisher Site | Google Scholar
  115. Y. Y. Liu, X. Q. Yang, D. Zhu, R. Shi, and Q. M. Luo, “Optical clearing agents improve photoacoustic imaging in the optical diffusive regime,” Optics Letters, vol. 38, no. 20, p. 4236, 2013. View at: Publisher Site | Google Scholar
  116. M. Brezinski, K. Saunders, C. Jesser, X. Li, and J. Fujimoto, “Index matching to improve optical coherence tomography imaging through blood,” Circulation, vol. 103, no. 15, pp. 1999–2003, 2001. View at: Publisher Site | Google Scholar
  117. V. D. Genin, E. A. Genina, V. V. Tuchin, and A. N. Bashkatov, “Glycerol effects on optical, weight and geometrical properties of skin tissue,” Journal of Innovative Optical Health Sciences, vol. 14, no. 5, 2021. View at: Publisher Site | Google Scholar
  118. L. Guo, R. Shi, C. Zhang, D. Zhu, Z. Ding, and P. Li, “Optical coherence tomography angiography offers comprehensive evaluation of skin optical clearingin vivoby quantifying optical properties and blood flow imaging simultaneously,” Journal of Biomedical Optics, vol. 21, no. 8, article 081202, 2016. View at: Publisher Site | Google Scholar
  119. R. Shi, L. Guo, C. Zhang et al., “A useful way to develop effectivein vivoskin optical clearing agents,” Journal of Biophotonics, vol. 10, no. 6-7, pp. 887–895, 2016. View at: Publisher Site | Google Scholar
  120. A. Milgroom, M. Intrator, K. Madhavan et al., “Mesoporous silica nanoparticles as a breast-cancer targeting ultrasound contrast agent,” Colloid Surface B, vol. 116, pp. 652–657, 2014. View at: Publisher Site | Google Scholar
  121. J. B. Travers, C. Poon, D. J. Rohrbach et al., “Noninvasive mesoscopic imaging of actinic skin damage using spatial frequency domain imaging,” Biomedical Optics Express, vol. 8, no. 6, p. 3045, 2017. View at: Publisher Site | Google Scholar
  122. B. H. Oh, K. H. Kim, and K. Y. Chung, “Skin imaging using ultrasound imaging, optical coherence tomography, confocal microscopy, and two-photon microscopy in cutaneous oncology,” Frontiers in Medicine, vol. 6, 2019. View at: Publisher Site | Google Scholar
  123. T. S. Ralston, D. L. Marks, P. S. Carney, and S. A. Boppart, “Inverse scattering for optical coherence tomography,” Journal of the Optical Society of America A, vol. 23, no. 5, pp. 1027–1037, 2006. View at: Publisher Site | Google Scholar
  124. C. Costa, A. Bradu, J. Rogers, P. Phelan, and A. Podoleanu, “Swept source optical coherence tomography gabor fusion splicing technique for microscopy of thick samples using a deformable mirror,” Journal of Biomedical Optics, vol. 20, no. 1, article 016012, 2015. View at: Publisher Site | Google Scholar
  125. P. N. Garcia, W. Chamon, and N. Allemann, “Comparability of corneal thickness and opacity depth assessed by oct and ubm,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 259, no. 7, pp. 1915–1923, 2021. View at: Publisher Site | Google Scholar
  126. A. Dubois, O. Levecq, H. Azimani et al., “Line-field confocal optical coherence tomography for high-resolution noninvasive imaging of skin tumors,” Journal of Biomedical Optics, vol. 23, no. 10, 2018. View at: Publisher Site | Google Scholar
  127. S. W. Ye, Y. X. Yin, J. Yao et al., “Axial resolution improvement of two-photon microscopy by multi-frame reconstruction and adaptive optics,” Biomedical Optics Express, vol. 11, no. 11, p. 6634, 2020. View at: Publisher Site | Google Scholar
  128. Y. F. Gao, L. N. Liu, Y. X. Yin et al., “Adaptive optics via pupil ring segmentation improves spherical aberration correction for two-photon imaging of optically cleared tissues,” Optics Express, vol. 28, no. 23, article 34935, 2020. View at: Publisher Site | Google Scholar
  129. A. Davis, O. Levecq, H. Azimani, D. Siret, and A. Dubois, “Simultaneous dual-band line-field confocal optical coherence tomography: application to skin imaging,” Biomedical Optics Express, vol. 10, no. 2, p. 694, 2019. View at: Publisher Site | Google Scholar
  130. J. L. Liao, Y. X. Yin, J. Yu et al., “Depth-resolved NIR-II fluorescence mesoscope,” Biomedical Optics Express, vol. 11, no. 5, pp. 2366–2372, 2020. View at: Publisher Site | Google Scholar
  131. L. V. Wang and J. Yao, “A practical guide to photoacoustic tomography in the life sciences,” Nature Methods, vol. 13, no. 8, pp. 627–638, 2016. View at: Publisher Site | Google Scholar
  132. S. Jeon, J. Kim, D. Lee, J. W. Baik, and C. Kim, “Review on practical photoacoustic microscopy,” Photoacoustics, vol. 15, article 100141, 2019. View at: Publisher Site | Google Scholar
  133. C. Zhang, K. Maslov, S. Hu et al., “Reflection-mode submicron-resolution in vivo photoacoustic microscopy,” Journal of Biomedical Optics, vol. 17, no. 2, article 020501, 2012. View at: Publisher Site | Google Scholar
  134. R. E. Lutton, J. Moore, E. Larraneta, S. Ligett, A. D. Woolfson, and R. F. Donnelly, “Microneedle characterisation: the need for universal acceptance criteria and gmp specifications when moving towards commercialisation,” Drug Delivery and Translational Research, vol. 5, no. 4, pp. 313–331, 2015. View at: Publisher Site | Google Scholar
  135. P. Li, M. Johnstone, and R. K. Wang, “Full anterior segment biometry with extended imaging range spectral domain optical coherence tomography at 1340 nm,” Journal of Biomedical Optics, vol. 19, no. 4, 2014. View at: Publisher Site | Google Scholar
  136. P. Li, L. Zhou, Y. Ni, Z. Ding, and P. Li, “Angular compounding by full-channel b-scan modulation encoding for optical coherence tomography speckle reduction,” Journal of Biomedical Optics, vol. 21, no. 8, article 86014, 2016. View at: Publisher Site | Google Scholar
  137. I. Grulkowski, M. Gora, M. Szkulmowski et al., “Anterior segment imaging with spectral oct system using a high-speed cmos camera,” Optics Express, vol. 17, no. 6, p. 4842, 2009. View at: Publisher Site | Google Scholar
  138. P. Li, L. An, G. Lan, M. Johnstone, D. Malchow, and R. K. Wang, “Extended imaging depth to 12 mm for 1050-nm spectral domain optical coherence tomography for imaging the whole anterior segment of the human eye at 120-khz a-scan rate,” Journal of Biomedical Optics, vol. 18, no. 1, article 016012, 2013. View at: Publisher Site | Google Scholar
  139. P. Li, X. Yin, L. Shi, S. Rugonyi, and R. K. Wang, “In vivo functional imaging of blood flow and wall strain rate in outflow tract of embryonic chick heart using ultrafast spectral domain optical coherence tomography,” Journal of Biomedical Optics, vol. 17, no. 9, article 96006, 2012. View at: Publisher Site | Google Scholar
  140. D. Seong, D. Jeon, R. E. Wijesinghe et al., “Ultrahigh-speed spectral-domain optical coherence tomography up to 1-mhz a-scan rate using space–time-division multiplexing,” IEEE Transactions on Instrumentation and Measurement, vol. 70, 2021. View at: Publisher Site | Google Scholar
  141. S. Zhang, L. Liu, S. Ren, Z. Li, and J. Qu, “Recent advances in nonlinear optics for bio-imaging applications,” Opto-Electronic Advances, vol. 3, no. 10, pp. 200003–200003, 2020. View at: Publisher Site | Google Scholar

Copyright © 2022 Yanni Wang et al. Exclusive Licensee Science and Technology Review Publishing House. Distributed under a Creative Commons Attribution License (CC BY 4.0).

 PDF Download Citation Citation
Altmetric Score